TheStreet Network:
TheStreet
|
MainStreet
|
BankingMyWay
|
RealMoney
Home
About Stockpickr
|
How to Use
Portfolios
Professional
Warren Buffett
George Soros
T. Boone Pickens
Carl Icahn
» Most-Viewed
» Recently Updated
Stockpickr Spotlight
4 Turnarounds Poised for better days Ahead
Zombie Apocalypse Portfolio
2 Stocks That Will Double in 2013
Less-Volatile Stocks for a Volatile World
5 Small-Cap Bank Stock Plays for 2013 From Credit Suisse
» More Spotlight Portfolios
User Generated
Recently Updated
Tools
Market Indicators
Top % Gainers
Top % Losers
52-Week Highs
52-Week Lows
Rising on Unusual Volume
Unusual Options Activity
Upgrades and Downgrades
Analyst Upgrades
Analyst Downgrades
TheStreet Ratings Upgrades
TheStreet Ratings Downgrades
Daily Lists
Cramer's "Lightning Round"
Insider Buying
Insider Selling
Earnings Announcements
Ex-Dividend Stocks
Dogs of the Dow
Articles
4 Huge Stocks Ripe for a Sharp Pullback
3 Tech Stocks Spiking on Big Volume
5 Stocks Soaring on Unusual Volume
5 Stocks Poised for Breakouts
5 Dividend Stocks Getting Ready to Hike Payouts
» More Articles
My Stockpickr
Log In
|
Join for Free
Stock Game
Health Care: Drugs
TrovaGene Inc. (TROV: NASDAQ)
$6.89
-0.06 | -0.86%
05/24/13 - 04:00 PM ET
Quote
Ratings
Earnings
Fundamentals
Options Chain
Advanced Chart
Balance Sheet
Cash Flow
Income Statement
Growth Rates
Major Holders
Ratio Comparison
92.49K / 75.60K
Vol / Avg. Vol:
6.90 / 6.95
Open / Prev. Close:
6.71 - 7.10
Today's Range:
2.09 - 8.96
52 Wk Range:
0.29%
Performance YTD:
D
TheStreet Rating:
Find out if TROV is in Cramer's Portfolio
6-MONTH
CHART:
1-Day
|
5-Day
|
1-Month
|
3-Month
|
6-Month
|
1-Year
See Advanced Charting for TROV
Portfolios with
TROV
Portfolio Name
User Type
Contributor
Stocks Under-$10 Moving Hig...
Contributor
Stocks Under-$10 Setting Up...
Contributor
Stocks Under-$10 Moving Hig...
Contributor
Stocks Under-$10 Setting Up...
View All
Latest
TROV
Headlines from TheStreet
5 Stocks Under $10 Set to Soar
03.28.13 | 01:03 pm
5 Stocks Under $10 Poised for Breakouts
09.07.12 | 11:09 am
More Financial News for TROV
Press Releases for
TROV
Highline Research Advisors Initiates Coverage On Trovagene (NASDAQ:TROV) With A Buy Rating.
- PR Newswire 05.06.13 | 09:05 am
Trovagene Launches Urine-Based HPV Test
- PR Newswire 03.27.13 | 05:03 am
Trovagene To Present At 25th Annual Roth Conference
- PR Newswire 03.12.13 | 09:03 am
Trovagene Appoints Mark Erlander, Ph.D. As Chief Scientific Officer
- PR Newswire 03.04.13 | 05:03 am
Trovagene Announces Commercial Launch Timelines For HPV Carrier And Oncogene Mutation Tests
- PR Newswire 02.12.13 | 05:02 am
Trovagene To Present At Leerink Swan Global Healthcare Conference
- PR Newswire 02.06.13 | 05:02 am
Trovagene To Study Transrenal BRAF Mutations In Primary And Metastatic Cancers
- PR Newswire 01.03.13 | 05:01 am
Trovagene, Inc., Grants License For NPM1 Marker For Acute Myelogenous Leukemia To Leading Academic Medical Center
- PR Newswire 12.27.12 | 05:12 am
Trovagene, Inc., Continues To Expand NPM1 Licensing Program For Acute Myelogenous Leukemia
- PR Newswire 12.20.12 | 05:12 am
Trovagene To Introduce First Urine-Based Molecular Diagnostic Test For Transrenal Cancer Mutation Monitoring
- PR Newswire 11.28.12 | 04:11 am
See All Press Releases
Partner Headlines for
TROV
Children’s Place Price Target is Cut and 3 More Analyst Notes to Read Now
- Wall St. Cheat Sheet 04.01.13 | 04:04 am
Children’s Place Price Target is Cut and 3 More Analyst Notes to Read Now
- Wall St. Cheat Sheet 04.01.13 | 04:04 am
Stock Watch Thursday, 20 December
- Seeking Alpha 12.20.12 | 09:12 am
Refresh Stock Quote for TrovaGene Inc. - TROV
Ratings Moves: ING,...
Time to Invest in L...
Start-Ups Swimming ...
Home
About Stockpickr
How to Use
Join for FREE
STOCK GAME
Portfolios
Professional
Warren Buffett
George Soros
T. Boone Pickens
Carl Icahn
Most-Viewed
Recently Updated
Stockpickr Spotlight
4 Turnarounds Poised for better days Ahead
Zombie Apocalypse Portfolio
2 Stocks That Will Double in 2013
Less-Volatile Stocks for a Volatile World
5 Small-Cap Bank Stock Plays for 2013 From Credit Suisse
More Spotlight Portfolios
User Generated
Recently Updated
Tools
Market Indicators
Top % Gainers
Top % Losers
52-Week Highs
52-Week Lows
Rising on Unusual Volume
Unusual Options Activity
Upgrades and Downgrades
Analyst Upgrades
Analyst Downgrades
TheStreet Ratings Upgrades
TheStreet Ratings Downgrades
Daily Lists
Cramer's "Lightning Round"
Insider Buying
Insider Selling
Earnings Announcements
Ex-Dividend Stocks
Dogs of the Dow
Articles
4 Huge Stocks Ripe for a Sharp Pullback
3 Tech Stocks Spiking on Big Volume
5 Stocks Soaring on Unusual Volume
5 Stocks Poised for Breakouts
5 Dividend Stocks Getting Ready to Hike Payouts
More Articles
My Stockpickr
My Stockpickr Profile
Inbox
Add New Portfolio
Edit My Profile